Low Dose Naltrexone (LDN) has been gaining attention for its potential in treating a variety of chronic conditions, including autoimmune diseases, cancer, chronic pain, and mental health disorders. But did you know that this treatment has been around for 20 years and has helped countless individuals around the world? This remarkable milestone is being celebrated in the newly released LDN 20-Year Anniversary Book, aptly titled “New Horizons.”
The book, published by the LDN Research Trust, a nonprofit charity, contains a collection of experiences and testimonials from LDN prescribers, pharmacists, researchers, and patients from all corners of the globe. “New Horizons” aims to educate and empower both patients and healthcare professionals about LDN by offering a mix of scientific insights and real-life experiences. The book showcases personal stories, case studies, and research on how LDN has positively impacted the lives of individuals struggling with difficult-to-treat conditions.
“I have witnessed the benefits of LDN myself, and this is why I am so happy to be able to prescribe it in my own wellness clinic,” shares Janis Oenbrink, MSN, APRN, FNP-C, owner of Emerald Key Wellness in Florida. “After suffering with long COVID, I found relief from so many symptoms when I started taking LDN. Reading this has been inspirational, and each day I hope to help my patients find the quality of life they have lost.” The book also features testimonials from physicians and healthcare professionals who have incorporated LDN into their practice and have seen remarkable results.
Joseph P. Navarra, RPh, FACA, FAPC, owner of Town Total Compounding Center, expresses his support for LDN by saying, “A must-read for anyone looking for an alternative therapy where nothing else has worked for their patients.”
The LDN Research Trust, founded by Linda Elsegood, has been a driving force in supporting and promoting the use of LDN for 17 years. After personally experiencing the positive effects of LDN in managing her multiple sclerosis, Elsegood made it her mission to spread awareness and education about this treatment option. “LDN can be life-changing, and it’s time it’s accepted and utilized for all the multitude of benefits,” says Elsegood.
The trust continues to provide support, education, and resources for patients and healthcare professionals through their website, radio show, documentaries, and regular events and seminars. As we celebrate the 20-year anniversary of LDN, “New Horizons” serves as a testament to the remarkable impact this treatment has on individuals struggling with chronic conditions. To learn more about “New Horizons” and the LDN Research Trust, visit ldnresearchtrust.org and join the movement to bring LDN into the spotlight for its potential to change lives.
